Tyra Biosciences
Stock Forecast, Prediction & Price Target
Tyra Biosciences (TYRA) stock Price Target by analysts
$30.5
Potential upside: 201.98%
Tyra Biosciences price prediction
What is Tyra Biosciences stock analysts` prediction?
Tyra Biosciences stock forecast: Based on 2 Wall Street analysts` predicted price targets for Tyra Biosciences in the last 3 months, the avarage price target is $30.5, with a high forecast of $NaN. The average price target represents a 201.98% change from the last price of $10.1.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Tyra Biosciences stock Price Target by analysts
Full breakdown of analysts given Tyra Biosciences price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Mitchell Kapoor H.C. Wainwright | 0% 0/3 | 11 months ago | $30 197.02% upside | $16.7 | StreetInsider | Previous targets (2) |
Jason Zemansky Bank of America Securities | 0% 0/1 | 11 months ago | $31 206.93% upside | $25.98 | StreetInsider | Previous targets (0) |
Matt Biegler Oppenheimer | 0% 0/1 | about 1 year ago | $33 226.73% upside | $24.65 | StreetInsider | Previous targets (0) |
Christopher Raymond Raymond James | 0% 0/1 | about 1 year ago | $33 226.73% upside | $21.57 | StreetInsider | Previous targets (0) |
Mitchell Kapoor H.C. Wainwright | 0% 0/3 | about 1 year ago | $25 147.52% upside | $19.5 | StreetInsider | Previous targets (2) |
Mitchell Kapoor H.C. Wainwright | 0% 0/3 | over 1 year ago | $23 127.72% upside | $17.37 | StreetInsider | Previous targets (2) |
Unknown Oppenheimer | N/A | over 2 years ago | $17 68.31% upside | $13.3 | Benzinga | N/A |
Tyra Biosciences Financial Estimates
Tyra Biosciences Revenue Estimates
Tyra Biosciences EBITDA Estimates
Tyra Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $2.64M Low: $2.64M High: $2.64M avg. 0% | Avg: $41.06M Low: $41.06M High: $41.06M avg. 1455.27% | Avg: $150.71M Low: $150.71M High: $150.71M avg. 266.98% |
Net Income
% change YoY
| $-26.14M N/A | $-51.72M -97.86% | $-69.13M -33.66% | Avg: $-127.07M Low: $-108.89M High: $-73.45M avg. -83.81% | Avg: $-144.16M Low: $-120.42M High: $-82.84M avg. -13.44% | Avg: $-64.91M Low: $-64.91M High: $-64.91M avg. 54.97% | Avg: $-34.59M Low: $-34.59M High: $-34.59M avg. 46.71% |
EBITDA
% change YoY
| $-26.28M N/A | $-58.92M -124.15% | $-79.59M -35.06% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.63 N/A | -$1.23 -95.23% | -$1.62 -31.70% | Avg: -$2.09 Low: -$2.55 High: -$1.72 avg. -29.11% | Avg: -$2.33 Low: -$2.82 High: -$1.94 avg. -11.39% | Avg: -$1.52 Low: -$1.52 High: -$1.52 avg. 34.76% | Avg: -$0.81 Low: -$0.81 High: -$0.81 avg. 46.71% |
Operating Expenses
% change YoY
| $26.28M N/A | $58.92M 124.15% | $79.94M 35.66% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Tyra Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 1.10% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -108.89M, average is -127.07M and high is -73.45M.
What is Tyra Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 430.56% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Tyra Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 10.24% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$2.55, average is -$2.09 and high is $-1.72.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Tyra Biosciences stock. The most successful analyst is Mitchell Kapoor.